The largest database of trusted experimental protocols

Cd14 pe hcd14

Manufactured by BioLegend
Sourced in United States

CD14 PE (HCD14) is a fluorochrome-conjugated monoclonal antibody that binds to the CD14 cell surface receptor. CD14 is a glycosylphosphatidylinositol (GPI)-anchored protein that serves as a co-receptor for the detection of bacterial lipopolysaccharide (LPS). The PE fluorochrome allows for the detection and analysis of CD14-expressing cells using flow cytometry.

Automatically generated - may contain errors

3 protocols using cd14 pe hcd14

1

Myeloid APC Depletion Impacts TIL Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In some experiments, myeloid antigen presenting cells (APCs) were removed from the tumor digest cultures. Briefly, tumor was dissociated as above. A small aliquot of dissociated tumor material was used to phenotype APCs by FACS as described above. Following the staining, myeloid cells were removed by positive magnetic selection with CD11b PE (D12), CD11c PE (S-HCL-3, both from BD Biosciences), CD14 PE (HCD14) and CD68 PE (Y1/B2A, both from BioLegend), followed by anti-PE magnetic beads (Miltenyi). Residual cells were stained with carboxy-fluorescein diacetate succinimidyl ester (CFSE, ThermoFischer Scientific) to later assess TIL proliferation (see below). Cultures were then either resupplied with the same amount of APCs or left APC-free. Cultures were treated with PD-1, CTLA-4, control Ab as above, or predicted CD28 antagonist peptide p2TA (1 μg/ml) or p2TA scramble, synthetized at the Protein and Peptide Chemistry Facility of the University of Lausanne. After 3–4 days in culture, CD8 cells were analyzed by FACS to assess CFSE dilution, as described above.
+ Open protocol
+ Expand
2

Immunophenotyping of Primary Ad-MSCs and hTERT-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary Ad-MSCs at passage four and hTERT-MSCs were harvested using TrypLE Express (Life Technologies, Carlsbad, California, USA). The cells were then stained using the following antibody or antibody cocktails and acquired on FACSCanto II (Becton, Dickinson and Company, Franklin Lakes, NJ, USA):

Cocktail 1: CD14-PE (HCD14, Biolegend, San Diego, CA, USA) and CD73-eFluor450 (AD2, Thermo Fisher Scientific).

Cocktail2: HLA-DR FITC (L243, Thermo Fisher Scientific), CD105 eFluor450 (SN6, Thermo Fisher Scientific), CD90-FITC (5E10, Biolegend), and CD45-PE (2D1, Biolegend).

Antihuman CD284 (TLR4) PE (HTA125, BioLegend).

+ Open protocol
+ Expand
3

Exosome Binding Assay with PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from buffy coat preparations of healthy blood donors (Blood Transfusion Center Solna, Stockholm, Sweden) through Ficoll-Paque Plus separation (GE Healthcare), as previously described (25 (link)). Exosomes (10 µg) were stained with a PKH67 Green Fluorescent Cell Linker Kit (Sigma-Aldrich), as previously described (25 (link)). Prefiltered (0.22-µm filter) PKH67-stained exosomes were added to PBMCs (2.5 × 105) for 1, 2, or 4 h at 37°C, 5% CO2. A PKH67 dye pellet centrifuged in parallel with labeled exosomes served as negative background control. PBMCs were stained with the following Abs to distinguish B cells (CD3CD19+HLA-DR+), monocytes (CD3CD14+HLA-DR+), and T cells (CD3+CD19): CD19-ECD (HD237; B4 lytic; Beckman Coulter); HLA-DR–PE-Cy5 (TU36; BD Biosciences), CD14-PE (HCD14; BioLegend), and CD3 Pacific Blue (SP34-2; BD Biosciences). Exosome binding to live PBMCs (LIVE/DEAD Fixable Aqua Dead Cell Stain Kit; Invitrogen) was measured (~150,000 events) using an LSR Fortessa (BD) or FACSAria (BD) and analyzed using FlowJo software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!